Salivary Gland Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Gene expression profiling in a validation cohort of locally advanced and recurrent/metastatic salivary gland cancers
Conditions: Salivary Gland Cancer Interventions: Other: Observation Sponsors: Royal Marsden NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Salivary Gland Cancers
Conditions: Gland; Salivary Gland Cancers Intervention: Drug: Sacituzumab Govitecan Sponsors: M.D. Anderson Cancer Center; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2023 Category: Research Source Type: clinical trials
Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers
Conditions: Locally Advanced Salivary Gland Carcinoma; Metastatic Salivary Gland Carcinoma; Recurrent Salivary Gland Carcinoma; Unresectable Salivary Gland Carcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Darolutamide; Drug: Leuprolide Acetate Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2023 Category: Research Source Type: clinical trials